Up again - 21%. Has the penny finally dropped with22 May 2026 09:04
One or more top Worldwide pharma Co's? I shall spell it out. Analysing CfDna cannot and will not ever replace entirely the information you can get from analysisng circulating tumor cells (CTC's), no matter how well your sales people promote the idea that analysing CfDna is how to make shareholders rich. Grail found this out when their share price dropped 50% a few weeks back!!!!!!!!!! Cellbxhealths Parsortix machine can catch CTC's that are live, intact and uncontaminated, perfect for analysis. Simple as that. This is where the missing 10% or so of the information can be obtained..................
All IMHO.